Market Research Logo

Global Oncology Molecular Diagnostics Market 2015-2019

About oncology molecular diagnostics

Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing.

Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.

Technavio's analysts forecast the global oncology molecular diagnostics market to grow at a CAGR of 17.8% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global oncology molecular diagnostics market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of diagnostics assay kits and instruments for cancers, which include:

  • Breast
  • Colorectal
  • Prostate
  • Others (including lung and cervical cancers)
Technavio's report, Global Oncology Molecular Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
  • APAC
  • Europe
  • Latin America
  • MEA
  • North America
Key vendors
  • Abbott Diagnostics
  • Becton, Dickinson and Company
  • QIAGEN
  • Roche Diagnostics
Other prominent vendors
  • Agendia
  • Angsana Molecular and Diagnostics
  • Asuragen
  • Autogenomics
  • Beckman Coulter
  • bioMérieux
  • bioTheranostics (Formerly AviaraDx)
  • Cangen Biotechnologies
  • Cepheid
  • Diagnocure
  • Epigenomics
  • Eragen
  • EXACT Sciences
  • Exiqon
  • GeneNews
  • Genera Biosystems
  • Genomic Health
  • Genomix Biotech
  • Health Discovery
  • HTG Molecular
  • Hologic
  • Innogenetics
  • Intergenetics
  • Kreatech Holding
  • Myriad Genetics
  • Nanosphere
  • NorDiag
  • Nuvera Biosciences
  • OncoMethylome Sciences
  • Orion Genomics
  • Prediction Sciences
  • Predictive Biosciences
  • Rosetta Genomics
  • SensiGen
  • Source MDx
  • Vermillion
Market driver
  • Increase in demand for personalized medicines
  • For a full, detailed list, view our report
Market challenge
  • Ethical, privacy, and practical issues
  • For a full, detailed list, view our report
Market trend
  • Advances in mass spectrometry
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Oncology Molecular Diagnostics Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Oncology Molecular Diagnostics Market: Abbott Diagnostics, Becton, Dickinson and Company, QIAGEN and Roche Diagnostics
Other Prominent Vendors in the market are: Agendia, Angsana Molecular and Diagnostics, Asuragen, Autogenomics, Beckman Coulter, bioMérieux, bioTheranostics (Formerly AviaraDx), Cangen Biotechnologies, Cepheid, Diagnocure, Epigenomics, Eragen, EXACT Sciences, Exiqon, GeneNews, Genera Biosystems, Genomic Health, Genomix Biotech, Health Discovery, HTG Molecular, Hologic, Innogenetics, Intergenetics, Kreatech Holding, Myriad Genetics, Nanosphere, NorDiag, Nuvera Biosciences, OncoMethylome Sciences, Orion Genomics, Prediction Sciences, Predictive Biosciences, Rosetta Genomics, SensiGen, Source MDx and Vermillion
Commenting on the report, an analyst from Technavio’s team said: “Mass spectrometry is an extremely sophisticated instrumentation technology that is of significant importance in molecular diagnostics. The technology relates to an increase in the throughput and coverage of complex proteome or genome analysis. It can also provide accurate results from small amounts of biological material and does not require specially purified samples. The technology may soon be used for diagnostic purposes in complex surgeries. The technology and will also find significant applications in the areas of genomics, lipidomics, metabolomics, forensics, data analysis, and environmental monitoring. In the coming years, this technology will produce breakthrough advances by characterizing macromolecules during diagnosis and determining therapy for patients who do not respond to many treatments.”
According to the report, proteins and genes control the biochemical functions of the body. Any defect in the structure of a particular protein or gene can lead to specific conditions and disorders. The development of personalized drugs depends on the identification and study of protein and gene expressions. These drugs are customized to an individual's protein or genetic profiles. Personalized medicines have high demand in oncology therapy since conventional cancer drug therapies fail to achieve desired patient outcomes. Many pharmaceutical companies are now developing personalized medicines to provide better patient management.
Further, the report states that insurance coverage and reimbursement issues is affecting the market growth.

Companies Mentioned

Abbott Diagnostics, Becton, Dickinson and Company, QIAGEN, Roche Diagnostics, Agendia, Angsana Molecular and Diagnostics, Asuragen, Autogenomics, Beckman Coulter, bioMérieux, bioTheranostics (Formerly AviaraDx), Cangen Biotechnologies, Cepheid, Diagnocure, Epigenomics, Eragen, EXACT Sciences, Exiqon, GeneNews, Genera Biosystems, Genomic Health, Genomix Biotech, Health Discovery, HTG Molecular, Hologic, Innogenetics, Intergenetics, Kreatech Holding, Myriad Genetics, Nanosphere, NorDiag, Nuvera Biosciences, OncoMethylome Sciences, Orion Genomics, Prediction Sciences, Predictive Biosciences, Rosetta Genomics, SensiGen, Source MDx ,Vermillion

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
      • Table Snapshot of global oncology molecular diagnostics market 2015-2019
  • Cancer statistics
    • Table Prevalent cancers worldwide 2012
    • Table Countries with highest cancer rates 2012
    • Table Cancer by gender 2012
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global oncology molecular diagnostics market 2014-2019 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Reimbursement and coverage: An overview
    • Table Reimbursement perspectives of healthcare entities
  • Molecular diagnostic products: Pricing scenario
    • Table Factors influencing price of molecular diagnostic products
  • Market segmentation by cancer type
    • Table Global oncology molecular diagnostics market segmentation by cancer type
    • Breast cancer
    • Colorectal cancer
    • Prostate cancer
    • Other cancers
      • Table Global oncology molecular diagnostics market segmentation by cancer type 2014
      • Table Global oncology molecular diagnostics market by cancer type 2014 ($ millions)
  • Geographical segmentation
    • Table Global oncology molecular diagnostics market segmentation by geography 2014
    • Table Global oncology molecular diagnostics market segmentation by geography 2019
    • Table Global oncology molecular diagnostics market by geography 2014-2019
    • Oncology molecular diagnostics market in Americas
      • Table Oncology molecular diagnostics market in Americas 2014-2019 ($ millions)
    • Oncology molecular diagnostics market in EMEA
      • Table Oncology molecular diagnostics market in EMEA 2014-2019 ($ millions)
    • Oncology molecular diagnostics market in APAC
      • Table Oncology molecular diagnostics market in APAC 2014-2019 ($ millions)
  • Market drivers
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Competitive scenario
    • Market share analysis 2014
      • Table Abbott: Key takeaways
      • Table Becton, Dickinson: Key takeaways
      • Table Qiagen: Key takeaways
      • Table Roche Diagnostics: Key takeaways
    • Other prominent vendors
  • Key vendor analysis
    • Abbott Diagnostics
      • Table Abbott Diagnostics: Key business offerings
    • Becton, Dickinson
      • Table Becton, Dickinson: Business segmentation by revenue 2014
      • Table Becton, Dickinson: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Becton, Dickinson: Geographical segmentation by revenue 2014
    • Qiagen
      • Table Segmentation of Qiagen's business by revenues 2014
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report